Unlocking the Potential of FAM90A2P as a Drug Target or Biomarker

Target Name: FAM90A2P

NCBI ID: G729689

FAM90A2P

Other Name(s): family with sequence similarity 90 member A2, pseudogene | Family with sequence similarity 90 member A2, pseudogene

Unlocking the Potential of FAM90A2P as a Drug Target or Biomarker

Introduction

FAM90A2P, a protein encoded by the gene FAM90A2P (family with sequence similarity 90 member A2, pseudogene), is a key regulator of various cellular processes. FAM90A2P plays a crucial role in the development, maintenance, and progression of tissues, including the brain, and has been implicated in numerous diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

Recent studies have identified FAM90A2P as a potential drug target or biomarker, highlighting its potential impact on human health. In this article, we will explore the biology and significance of FAM90A2P, discuss its potential as a drug target, and examine its potential as a biomarker for various diseases.

FAM90A2P: Structure and Function

FAM90A2P is a member of the FAM90A family, which includes several conserved transcription factors. These transcription factors are involved in the regulation of gene expression and are characterized by the presence of a conserved transcription factor binding site (FAM) and a unique N-terminal region.

FAM90A2P is a 21-kDa protein that consists of 1,964 amino acids. Its N-terminal region contains a FAM domain, which is responsible for its unique structural features and functions as a protein-protein interaction site. FAM90A2P also contains a unique C-terminal region that is involved in its stability and functions as a scaffold.

FAM90A2P is involved in various cellular processes, including cell adhesion, migration, and the regulation of cellular signaling pathways. Its function is highly conserved across various species, which suggests its relevance to human health.

Potential as a Drug Target

FAM90A2P has been identified as a potential drug target due to its unique structure and function. Several studies have demonstrated that FAM90A2P can be targeted by small molecules, including inhibitors of its FAM domain, C-terminal region, or other non-covalent interactions.

One of the most promising strategies for targeting FAM90A2P is the use of small molecules that can inhibit its FAM domain. Several studies have shown that inhibitors of the FAM domain can effectively inhibit FAM90A2P's activity and reduce its contribution to cellular processes, including cell adhesion and migration.

FAM90A2P has also been identified as a potential biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Its conservation across various species and its involvement in various cellular processes make it an attractive candidate for use as a biomarker.

Potential as a Biomarker

FAM90A2P has been shown to play a crucial role in the development and progression of various diseases. Its involvement in these diseases makes it an attractive candidate as a biomarker.

For example, several studies have shown that individuals with certain genetic variations in the FAM90A2P gene are at increased risk for the development of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. These genetic variations have been associated with disruptions in the normal function of FAM90A2P, leading to its dysfunction and increased risk of disease.

FAM90A2P has also been shown to be involved in the development and progression of cancer. Its involvement in cell signaling pathways has been identified as a potential target for cancer therapies. In addition, FAM90A2P has been shown to play a crucial role in the regulation of cellular processes, including cell adhesion and migration, which are implicated in the development and progression of cancer.

In conclusion, FAM90A2P is a unique protein that has the potential to be a drug target or biomarker. Its conservation across various species and its involvement in various cellular processes make it an attractive candidate for both research and clinical applications. Further studies are needed to fully understand its role in

Protein Name: Family With Sequence Similarity 90 Member A2, Pseudogene

The "FAM90A2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets